Physician profile
Jonathan B Weinstein
NPI 1588838700
$2,250.21
in general payments reported to CMS, 2019-2025
14 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $128 · 2021: $376 · 2022: $31.53 · 2023: $148 · 2024: $191 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977 · Travel and Lodging: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.52 |
| Travel and Lodging | $591.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $707.19 | 2024-2025 | Cobalt Dr Mri Surescan, Micra, Corevalve Evolut R |
| Histosonics, INC. | $591.82 | 2025 | |
| Edwards Lifesciences Corporation | $304.82 | 2020-2021 | |
| Boston Scientific Corporation | $188.93 | 2021-2025 | Rotapro, Avvigo Guidance System |
| Abbott Laboratories | $148.95 | 2021 | |
| Medtronic Vascular, INC. | $138.60 | 2019-2020 | |
| Baxter Healthcare | $62.18 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $21.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $20.05 | 2019 | |
| Teleflex LLC | $19.12 | 2025 | Chocolate |
| Heartflow, INC. | $17.06 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.40 | 2025 | |
| Cardiva Medical, INC. | $14.47 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.